The immunotherapy field is definitely starting to get exciting and interest from the big guys is there:
Roche today made a $10 million down payment to expand its work in the hot cancer immunotherapy field, promising Inovio up to $412.5 million in milestones and dangling the prospects of additional payments if the work takes off. The deal puts Roche--a leader in oncology and a top contender in the immunotherapy field--in the driver's seat on two preclinical therapies that could help marshal a targeted T-cell attack on cancer.
Read more: Roche's cancer immunotherapy quest spurs $422.5M Inovio combo deal - FierceBiotech http://www.fiercebiotech.com/story/roches-cancer-immunotherapy-quest-spurs-4225m-inovio-combo-deal/2013-09-10#ixzz2eXVzar1Z
big pharma
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.010(3.08%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.0¢ | $584.2K | 1.787M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 311433 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 113721 | 6 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |